--- title: "US High Growth Tech Stocks To Watch In July 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/294353486.md" description: "The article highlights top US high-growth tech stocks for July 2026, including Krystal Biotech, Palantir Technologies, and Western Digital. It details their revenue and earnings growth, market capitalization, and strategic developments such as AI integration and R&D investments. The piece serves as an investment research overview, analyzing company performance and future potential within the dynamic tech sector." datetime: "2026-07-30T11:13:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294353486.md) - [en](https://longbridge.com/en/news/294353486.md) - [zh-HK](https://longbridge.com/zh-HK/news/294353486.md) --- # US High Growth Tech Stocks To Watch In July 2026 Over the last 7 days, the United States market has experienced a 2.6% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 17% annually. In this dynamic environment, identifying high growth tech stocks involves evaluating companies that demonstrate strong innovation and adaptability to capitalize on evolving market trends. ### Top 10 High Growth Tech Companies In The United States Name Revenue Growth Earnings Growth Growth Rating AppLovin 21.14% 21.74% ★★★★★★ Fabrinet 20.12% 22.27% ★★★★★★ Krystal Biotech 29.71% 35.79% ★★★★★★ Lumentum Holdings 42.94% 56.54% ★★★★★★ Super Micro Computer 24.16% 22.40% ★★★★★★ AnaptysBio 20.47% 48.14% ★★★★★★ Marker Therapeutics 64.28% 69.04% ★★★★★★ Syndax Pharmaceuticals 28.32% 68.06% ★★★★★★ Madrigal Pharmaceuticals 28.70% 59.24% ★★★★★★ Travere Therapeutics 23.50% 50.79% ★★★★★★ Click here to see the full list of 20 stocks from our US High Growth Tech and AI Stocks screener. We'll examine a selection from our screener results. ## Krystal Biotech (KRYS) **Simply Wall St Growth Rating:** ★★★★★★ **Overview:** Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing genetic medicines to address diseases with high unmet medical needs in the United States, with a market capitalization of approximately $10.74 billion. **Operations:** Krystal Biotech generates revenue primarily from its activities in discovering, developing, manufacturing, and commercializing genetic medicines, with reported revenue of $417.30 million. The company is positioned within the biotechnology sector and operates exclusively in the United States to address diseases with high unmet medical needs. Krystal Biotech, a trailblazer in gene therapy for dermatological diseases, has shown remarkable growth with an 81.5% increase in earnings over the past year, outpacing the biotech industry's 64.1%. This surge is underpinned by robust R&D investments aimed at pioneering treatments like KB801 for neurotrophic keratitis. Recent approvals, such as VYJUVEK in the UK for treating dystrophic epidermolysis bullosa, underscore its commitment to addressing rare genetic disorders. Despite dropping from the S&P 600 Health Care Sector, Krystal was added to the S&P 400, reflecting its evolving market stature and investor confidence fueled by a forecasted annual earnings growth of 35.8% and revenue growth of 29.7%. - Unlock comprehensive insights into our analysis of Krystal Biotech stock in this health report. - Examine Krystal Biotech's past performance report to understand how it has performed in the past. KRYS Revenue and Expenses Breakdown as at Jul 2026 ## Palantir Technologies (PLTR) **Simply Wall St Growth Rating:** ★★★★★★ **Overview:** Palantir Technologies Inc. develops software platforms for intelligence agencies to support counterterrorism efforts globally, with a market cap of approximately $296.14 billion. **Operations:** Palantir Technologies generates revenue through two primary segments: Commercial, which contributed $2.45 billion, and Government, with $2.77 billion in revenue. The company focuses on building software platforms that aid intelligence agencies in counterterrorism operations across various regions, including the U.S. and the U.K. Palantir Technologies has demonstrated a robust integration of its AI and data analytics capabilities into diverse sectors, significantly enhancing operational efficiencies and fraud detection. Recently, the U.S. Small Business Administration deployed Palantir's software to bolster its anti-fraud initiatives across pandemic-era relief programs, showcasing the company's pivotal role in governmental operations. This strategic application aligns with Palantir’s 30.9% annual revenue growth and underscores its deepening penetration in critical public sector activities, further evidenced by a 31.9% surge in earnings annually. The firm's commitment to innovation is marked by substantial R&D investments amounting to $1 billion last year alone, positioning it as a key enabler of advanced data solutions in both government and private sectors. - Click here and access our complete health analysis report to understand the dynamics of Palantir Technologies. - Gain insights into Palantir Technologies' past trends and performance with our Past report. PLTR Earnings and Revenue Growth as at Jul 2026 ## Western Digital (WDC) **Simply Wall St Growth Rating:** ★★★★★★ **Overview:** Western Digital Corporation is a global company that specializes in the development, manufacturing, and sale of data storage devices and solutions using hard disk drive technology, with a market cap of approximately $159.76 billion. **Operations:** The company generates revenue primarily from the sale of hard disk drives (HDD), amounting to $11.78 billion. Amidst a dynamic tech landscape, Western Digital stands out with its strategic maneuvers and robust R&D commitment. The company's recent merger discussions with Kioxia could significantly enhance its position in the NAND flash sector, crucial for data-center and PC memory markets. This move follows a series of index adjustments, reflecting a nuanced market perception. Innovatively, at Computex 2026, Western Digital underscored its pivotal role in AI infrastructure by demonstrating advanced HDD technologies and storage solutions tailored for escalating data demands. These efforts are complemented by an aggressive R&D expenditure strategy that not only fuels innovation but also aligns with industry shifts towards more sophisticated data management systems. - Get an in-depth perspective on Western Digital's performance by reading our health report here. - Gain insights into Western Digital's historical performance by reviewing our past performance report. WDC Earnings and Revenue Growth as at Jul 2026 ## Where To Now? - Click here to access our complete index of 20 US High Growth Tech and AI Stocks. - Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. - Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. ## Curious About Other Options? - Explore high-performing small cap companies that haven't yet garnered significant analyst attention. - Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. - Find companies with promising cash flow potential yet trading below their fair value. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if Krystal Biotech might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [WDC.US](https://longbridge.com/en/quote/WDC.US.md) - [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md) - [PLTR.US](https://longbridge.com/en/quote/PLTR.US.md) - [PLTD.US](https://longbridge.com/en/quote/PLTD.US.md) - [PTIR.US](https://longbridge.com/en/quote/PTIR.US.md) - [PLTG.US](https://longbridge.com/en/quote/PLTG.US.md) - [PLTW.US](https://longbridge.com/en/quote/PLTW.US.md) - [PLOO.US](https://longbridge.com/en/quote/PLOO.US.md) - [PLT.US](https://longbridge.com/en/quote/PLT.US.md) - [PLTZ.US](https://longbridge.com/en/quote/PLTZ.US.md) - [PLTU.US](https://longbridge.com/en/quote/PLTU.US.md) - [WDCX.US](https://longbridge.com/en/quote/WDCX.US.md) - [PLTA.US](https://longbridge.com/en/quote/PLTA.US.md) - [PLTY.US](https://longbridge.com/en/quote/PLTY.US.md) - [PLYY.US](https://longbridge.com/en/quote/PLYY.US.md) - [APP.US](https://longbridge.com/en/quote/APP.US.md) - [FN.US](https://longbridge.com/en/quote/FN.US.md) - [LITE.US](https://longbridge.com/en/quote/LITE.US.md) - [SMCI.US](https://longbridge.com/en/quote/SMCI.US.md) - [ANAB.US](https://longbridge.com/en/quote/ANAB.US.md) - [MRKR.US](https://longbridge.com/en/quote/MRKR.US.md) - [SNDX.US](https://longbridge.com/en/quote/SNDX.US.md) - [MDGL.US](https://longbridge.com/en/quote/MDGL.US.md) - [TVTX.US](https://longbridge.com/en/quote/TVTX.US.md) - [WDCVV.US](https://longbridge.com/en/quote/WDCVV.US.md) ## Related News & Research - [Palantir Q2 Earnings Preview: Profit Growth Expected as Wall Street Sets $200 Price Target](https://longbridge.com/en/news/294017405.md) - [Is Western Digital (WDC) Expensive On The Chip Rally And AI Demand Hype?](https://longbridge.com/en/news/293952773.md) - [As Sam Altman Celebrates the Singularity, Palantir CEO Alex Karp Warns: ‘There Are Dangers… We Are Going to End Up Having to Regulate AI’](https://longbridge.com/en/news/294405179.md) - [Palantir CEO Alex Karp Says Al Will Create 'Unimaginable Wealth' for 'Oddly Shaped IQ Specimens You Wouldn't Want To Have Over for Dinner'](https://longbridge.com/en/news/293784389.md) - [‘It Skews One Way,’ Says Rosenblatt About Palantir Stock](https://longbridge.com/en/news/294383349.md)